Someone will be seriously hurt or die at an unregulated ketamine or psychedelic clinic in the US, the story will get attention, and Congress or a federal agency will hold a public hearing or launch a formal investigation. This matters because ketamine clinics are booming but barely regulated, and one high-profile disaster could reshape the whole industry.
Ketamine clinic expansion is rapid and largely unregulated at the federal level. Matthew Perry's death from ketamine in 2023 already demonstrated celebrity-case dynamics. The probability of at least one high-profile adverse event is moderate; the probability that it reaches congressional testimony or formal federal investigation is lower but non-trivial given ongoing congressional interest in the space.